Lung cancer - NYSORA

Explore NYSORA knowledge base for free:

Lung cancer

Learning objectives

  • Anesthetic management of lung cancer

Definition and mechanisms

  • Lung cancer is the most common cause of cancer mortality worldwide for men and women
  • Lung cancer or lung carcinoma is a malignant tumor characterized by uncontrolled cell growth in lung tissue
  • Lung carcinomas derive from transformed, malignant cells that originate as epithelial cells, or from tissues composed of epithelial cells
  • Sarcomas are generated by the malignant transformation of connective tissues, which arise from mesenchymal cells
  • Lung cancer often starts in the bronchi, bronchioles, or alveoli
  • Two types:
    • Non-small-cell lung cancer
      • The most common form, accounting for around 80% of lung cancer cases
      • Common types include: squamous cell carcinoma, adenocarcinoma, or large-cell carcinoma
    • Small-cell lung cancer 
      • Less common
      • Spreads faster and harder to treat than non-small-cell lung cancer
  • Other tumors including large cell, neuroendocrine (carcinoid), bronchioloalveolar and rarer forms can all present as lung malignancies
  • The presentation includes airway obstruction, lung collapse, and distal infection or through spread via the peribronchial tissues with subsequent invasion of the mediastinum
  • Spreads by both lymphatic and hematological routes and distal metastasis is common in the liver, adrenals, bone, and brain

Signs and symptoms

  • A persistent cough
  • Shortness of breath
  • Chest pain
  • Wheezing
  • Hemoptysis
  • Fatigue
  • Hoarseness
  • Weight loss
  • Bone pain
  • Headache
  • Swelling in the face, neck, arms, or upper chest (superior vena cava syndrome)

Risk factors

  • Smoking
  • Older age
  • Genetic mutations
  • Exposure to harmful substances such as air pollution, radon, asbestos, uranium, silica, coal products
  • Previous radiation treatment to the thorax
  • Family history of lung cancer

Diagnosis

  • Physical exam
  • Blood test
  • Chest X-ray
  • CT/PET
  • Biopsy

Management

  • Anesthetic involvement is mainly for lung resection (e.g. lobectomy, pneumonectomy)
  • Consider: 
    • Potentially compromised respiratory function with risk of perioperative respiratory complications
    • Mass effects: obstructive pneumonia, lung abscess, SVC syndrome, tracheobronchial distortion, Pancoast’s syndrome, recurrent laryngeal nerve or phrenic nerve paresis, chest wall or mediastinal extension
    • Metabolic effects: Lambert–Eaton syndrome, hypercalcemia, hyponatremia, Cushing’s syndrome
    • Metastases: particularly to the brain, bone, liver, & adrenal 
    • Medications: chemotherapy agents, pulmonary toxicity (bleomycin, mitomycin), cardiac toxicity (doxorubicin), renal toxicity (cisplatin)
    • Comorbidities including smoking, chronic obstructive lung disease, coronary artery disease, hypertension

Lung cancer, TNM, lung resection

Suggested reading

  • Hackett, S., Jones, R., Kapila, R., 2019. Anaesthesia for pneumonectomy. BJA Education 19, 297–304.
  • Pollard BJ, Kitchen, G. Handbook of Clinical Anaesthesia. Fourth Edition. CRC Press. 2018. 978-1-4987-6289-2.

We would love to hear from you. If you should detect any errors, email us customerservice@nysora.com